Skip to main content
. 2000 Jan;44(1):78–87. doi: 10.1128/aac.44.1.78-87.2000

FIG. 1.

FIG. 1

Clinical study NAIB2005. Median viral titer versus day of study is shown. ⧫, placebo (n = 16); ■, IH zanamivir (n = 19); ▴, IH plus IN zanamivir (n = 16). P = 0.623, IH versus placebo; P = 0.3, IH plus placebo, by AUC analysis. Limit of detection, 1.5 log10 TCID50s/ml.